Article
High Throughput Screening for Neurodegeneration and Complex Disease Phenotypes
1 Mar 2008
Abstract excerpt
High throughput screening (HTS) for complex diseases is challenging. This stems from the fact that complex phenotypes are difficult to adapt to rapid, high throughput assays. We describe the recent development of high throughput and high-content screens (HCS) for neurodegenerative diseases, with a focus on inherited neurodegenerative disorders, such as Huntington's disease. We describe, among others, HTS assays...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
